The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gene Deletion Vaccine Market Research Report 2025
Synopsis
Gene-deleted live attenuated vaccines, which are produced by the knockout of virulent gene(s) in the viral genome (Sun et al., 2014), could induce a long-lasting and broad immune response (humoral and cellular), which closely resembles natural immunity after infection
The global Gene Deletion Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Deletion Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Deletion Vaccine.
Report Scope
The Gene Deletion Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Deletion Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Deletion Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Virbac SA
Merck Animal Health
Zoetis Inc
Boehringer Ingelheim GmbH
Indian Immunologicals Ltd
Segment by Type
Single Gene Deletion Vaccine
Double Gene Deletion Vaccine
Segment by Application
Animal Health Center
Veterinary Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gene Deletion Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gene Deletion Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Gene-deleted live attenuated vaccines, which are produced by the knockout of virulent gene(s) in the viral genome (Sun et al., 2014), could induce a long-lasting and broad immune response (humoral and cellular), which closely resembles natural immunity after infection
The global Gene Deletion Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Deletion Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Deletion Vaccine.
Report Scope
The Gene Deletion Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Deletion Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Deletion Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Virbac SA
Merck Animal Health
Zoetis Inc
Boehringer Ingelheim GmbH
Indian Immunologicals Ltd
Segment by Type
Single Gene Deletion Vaccine
Double Gene Deletion Vaccine
Segment by Application
Animal Health Center
Veterinary Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gene Deletion Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gene Deletion Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Gene Deletion Vaccine Market Overview
1.1 Product Overview and Scope of Gene Deletion Vaccine
1.2 Gene Deletion Vaccine Segment by Type
1.2.1 Global Gene Deletion Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Single Gene Deletion Vaccine
1.2.3 Double Gene Deletion Vaccine
1.3 Gene Deletion Vaccine Segment by Application
1.3.1 Global Gene Deletion Vaccine Market Value by Application: (2024-2030)
1.3.2 Animal Health Center
1.3.3 Veterinary Clinic
1.3.4 Others
1.4 Global Gene Deletion Vaccine Market Size Estimates and Forecasts
1.4.1 Global Gene Deletion Vaccine Revenue 2019-2030
1.4.2 Global Gene Deletion Vaccine Sales 2019-2030
1.4.3 Global Gene Deletion Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gene Deletion Vaccine Market Competition by Manufacturers
2.1 Global Gene Deletion Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gene Deletion Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gene Deletion Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Gene Deletion Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gene Deletion Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gene Deletion Vaccine, Product Type & Application
2.7 Gene Deletion Vaccine Market Competitive Situation and Trends
2.7.1 Gene Deletion Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gene Deletion Vaccine Players Market Share by Revenue
2.7.3 Global Gene Deletion Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gene Deletion Vaccine Retrospective Market Scenario by Region
3.1 Global Gene Deletion Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gene Deletion Vaccine Global Gene Deletion Vaccine Sales by Region: 2019-2030
3.2.1 Global Gene Deletion Vaccine Sales by Region: 2019-2024
3.2.2 Global Gene Deletion Vaccine Sales by Region: 2025-2030
3.3 Global Gene Deletion Vaccine Global Gene Deletion Vaccine Revenue by Region: 2019-2030
3.3.1 Global Gene Deletion Vaccine Revenue by Region: 2019-2024
3.3.2 Global Gene Deletion Vaccine Revenue by Region: 2025-2030
3.4 North America Gene Deletion Vaccine Market Facts & Figures by Country
3.4.1 North America Gene Deletion Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gene Deletion Vaccine Sales by Country (2019-2030)
3.4.3 North America Gene Deletion Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gene Deletion Vaccine Market Facts & Figures by Country
3.5.1 Europe Gene Deletion Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gene Deletion Vaccine Sales by Country (2019-2030)
3.5.3 Europe Gene Deletion Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gene Deletion Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Gene Deletion Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gene Deletion Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Gene Deletion Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gene Deletion Vaccine Market Facts & Figures by Country
3.7.1 Latin America Gene Deletion Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gene Deletion Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Gene Deletion Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gene Deletion Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Gene Deletion Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gene Deletion Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gene Deletion Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gene Deletion Vaccine Sales by Type (2019-2030)
4.1.1 Global Gene Deletion Vaccine Sales by Type (2019-2024)
4.1.2 Global Gene Deletion Vaccine Sales by Type (2025-2030)
4.1.3 Global Gene Deletion Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Gene Deletion Vaccine Revenue by Type (2019-2030)
4.2.1 Global Gene Deletion Vaccine Revenue by Type (2019-2024)
4.2.2 Global Gene Deletion Vaccine Revenue by Type (2025-2030)
4.2.3 Global Gene Deletion Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Gene Deletion Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gene Deletion Vaccine Sales by Application (2019-2030)
5.1.1 Global Gene Deletion Vaccine Sales by Application (2019-2024)
5.1.2 Global Gene Deletion Vaccine Sales by Application (2025-2030)
5.1.3 Global Gene Deletion Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Gene Deletion Vaccine Revenue by Application (2019-2030)
5.2.1 Global Gene Deletion Vaccine Revenue by Application (2019-2024)
5.2.2 Global Gene Deletion Vaccine Revenue by Application (2025-2030)
5.2.3 Global Gene Deletion Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Gene Deletion Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Virbac SA
6.1.1 Virbac SA Corporation Information
6.1.2 Virbac SA Description and Business Overview
6.1.3 Virbac SA Gene Deletion Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Virbac SA Gene Deletion Vaccine Product Portfolio
6.1.5 Virbac SA Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Corporation Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Gene Deletion Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Animal Health Gene Deletion Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Zoetis Inc
6.3.1 Zoetis Inc Corporation Information
6.3.2 Zoetis Inc Description and Business Overview
6.3.3 Zoetis Inc Gene Deletion Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zoetis Inc Gene Deletion Vaccine Product Portfolio
6.3.5 Zoetis Inc Recent Developments/Updates
6.4 Boehringer Ingelheim GmbH
6.4.1 Boehringer Ingelheim GmbH Corporation Information
6.4.2 Boehringer Ingelheim GmbH Description and Business Overview
6.4.3 Boehringer Ingelheim GmbH Gene Deletion Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boehringer Ingelheim GmbH Gene Deletion Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.5 Indian Immunologicals Ltd
6.5.1 Indian Immunologicals Ltd Corporation Information
6.5.2 Indian Immunologicals Ltd Description and Business Overview
6.5.3 Indian Immunologicals Ltd Gene Deletion Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Indian Immunologicals Ltd Gene Deletion Vaccine Product Portfolio
6.5.5 Indian Immunologicals Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gene Deletion Vaccine Industry Chain Analysis
7.2 Gene Deletion Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gene Deletion Vaccine Production Mode & Process
7.4 Gene Deletion Vaccine Sales and Marketing
7.4.1 Gene Deletion Vaccine Sales Channels
7.4.2 Gene Deletion Vaccine Distributors
7.5 Gene Deletion Vaccine Customers
8 Gene Deletion Vaccine Market Dynamics
8.1 Gene Deletion Vaccine Industry Trends
8.2 Gene Deletion Vaccine Market Drivers
8.3 Gene Deletion Vaccine Market Challenges
8.4 Gene Deletion Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Gene Deletion Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gene Deletion Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gene Deletion Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gene Deletion Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Gene Deletion Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gene Deletion Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gene Deletion Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gene Deletion Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gene Deletion Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gene Deletion Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gene Deletion Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Gene Deletion Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gene Deletion Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Deletion Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gene Deletion Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gene Deletion Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Gene Deletion Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Gene Deletion Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Gene Deletion Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Gene Deletion Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gene Deletion Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Gene Deletion Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gene Deletion Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Gene Deletion Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gene Deletion Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Gene Deletion Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Gene Deletion Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gene Deletion Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gene Deletion Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gene Deletion Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Gene Deletion Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Gene Deletion Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gene Deletion Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gene Deletion Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gene Deletion Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Gene Deletion Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Gene Deletion Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gene Deletion Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gene Deletion Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gene Deletion Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Gene Deletion Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Gene Deletion Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gene Deletion Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gene Deletion Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gene Deletion Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Gene Deletion Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Gene Deletion Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gene Deletion Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gene Deletion Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Gene Deletion Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Gene Deletion Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Gene Deletion Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Gene Deletion Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gene Deletion Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gene Deletion Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Gene Deletion Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Gene Deletion Vaccine Price (USD/Unit) by Type (2019-2024)
Table 59. Global Gene Deletion Vaccine Price (USD/Unit) by Type (2025-2030)
Table 60. Global Gene Deletion Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Gene Deletion Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Gene Deletion Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Gene Deletion Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Gene Deletion Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gene Deletion Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gene Deletion Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Gene Deletion Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Gene Deletion Vaccine Price (USD/Unit) by Application (2019-2024)
Table 69. Global Gene Deletion Vaccine Price (USD/Unit) by Application (2025-2030)
Table 70. Virbac SA Corporation Information
Table 71. Virbac SA Description and Business Overview
Table 72. Virbac SA Gene Deletion Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Virbac SA Gene Deletion Vaccine Product
Table 74. Virbac SA Recent Developments/Updates
Table 75. Merck Animal Health Corporation Information
Table 76. Merck Animal Health Description and Business Overview
Table 77. Merck Animal Health Gene Deletion Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Merck Animal Health Gene Deletion Vaccine Product
Table 79. Merck Animal Health Recent Developments/Updates
Table 80. Zoetis Inc Corporation Information
Table 81. Zoetis Inc Description and Business Overview
Table 82. Zoetis Inc Gene Deletion Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Zoetis Inc Gene Deletion Vaccine Product
Table 84. Zoetis Inc Recent Developments/Updates
Table 85. Boehringer Ingelheim GmbH Corporation Information
Table 86. Boehringer Ingelheim GmbH Description and Business Overview
Table 87. Boehringer Ingelheim GmbH Gene Deletion Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Boehringer Ingelheim GmbH Gene Deletion Vaccine Product
Table 89. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 90. Indian Immunologicals Ltd Corporation Information
Table 91. Indian Immunologicals Ltd Description and Business Overview
Table 92. Indian Immunologicals Ltd Gene Deletion Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Indian Immunologicals Ltd Gene Deletion Vaccine Product
Table 94. Indian Immunologicals Ltd Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Gene Deletion Vaccine Distributors List
Table 98. Gene Deletion Vaccine Customers List
Table 99. Gene Deletion Vaccine Market Trends
Table 100. Gene Deletion Vaccine Market Drivers
Table 101. Gene Deletion Vaccine Market Challenges
Table 102. Gene Deletion Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gene Deletion Vaccine
Figure 2. Global Gene Deletion Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gene Deletion Vaccine Market Share by Type in 2023 & 2030
Figure 4. Single Gene Deletion Vaccine Product Picture
Figure 5. Double Gene Deletion Vaccine Product Picture
Figure 6. Global Gene Deletion Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Gene Deletion Vaccine Market Share by Application in 2023 & 2030
Figure 8. Animal Health Center
Figure 9. Veterinary Clinic
Figure 10. Others
Figure 11. Global Gene Deletion Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Gene Deletion Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Gene Deletion Vaccine Sales (2019-2030) & (K Units)
Figure 14. Global Gene Deletion Vaccine Average Price (USD/Unit) & (2019-2030)
Figure 15. Gene Deletion Vaccine Report Years Considered
Figure 16. Gene Deletion Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Gene Deletion Vaccine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Gene Deletion Vaccine Players: Market Share by Revenue in 2023
Figure 19. Gene Deletion Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Gene Deletion Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Gene Deletion Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Gene Deletion Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. United States Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Gene Deletion Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Gene Deletion Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Gene Deletion Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Gene Deletion Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Gene Deletion Vaccine Sales Market Share by Country (2019-2030)
Figure 44. Latin America Gene Deletion Vaccine Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Gene Deletion Vaccine Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Gene Deletion Vaccine Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Gene Deletion Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Gene Deletion Vaccine by Type (2019-2030)
Figure 54. Global Revenue Market Share of Gene Deletion Vaccine by Type (2019-2030)
Figure 55. Global Gene Deletion Vaccine Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Gene Deletion Vaccine by Application (2019-2030)
Figure 57. Global Revenue Market Share of Gene Deletion Vaccine by Application (2019-2030)
Figure 58. Global Gene Deletion Vaccine Price (USD/Unit) by Application (2019-2030)
Figure 59. Gene Deletion Vaccine Value Chain
Figure 60. Gene Deletion Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
